Risk Factors (Cont. 03)546. “If our common stock is delisted by Nasdaq, our common stock may be eligible for quotation on an over-the-counter quotation system or on the pink sheets.”
547. “Delisting from Nasdaq could adversely affect our ability to raise additional financing through public or private sales of equity securities.”
548. “This would significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our common stock.”
549. “We may not successfully implement our business strategies, including achieving our growth objectives.”
550. “If the FDA were to begin to enforce regulation of laboratory-developed tests, we could incur substantial costs and delays associated with trying to obtain pre-market clearance.”